In the past one week, PSU index has outperformed the market by gaining 1.5 per cent, as against 0.4 per cent decline in the BSE Sensex.
MGL's Q2FY26 results, analysts said, highlight near-term margin pressures, even as volume growth remains steady.
MOFSL expect momentum to sustain in 2HFY26, supported by the stable pricing environment of refrigerant gases, robust order book pipeline, and higher realizations and volumes.
In the Q2FY26, Cipla reported consolidated revenue from operations of ₹7,589 crore, up 8 per cent year-on-year (Y-o-Y) from ₹7,051 crore in the year-ago period
Swiggy's food delivery (FD) arm continued its solid performance in the September quarter (Q2FY26), driven by sustained order growth and operational efficiency.
ICICI Securities has maintained its Add rating on the stock with a revised target price of ₹1,550 per share (previously ₹1,450), while Nuvama has retained its Buy rating with a target price of ₹1710
CG Power's Q2FY26 earnings missed estimates on weak Industrial Systems margins, but strong Power Systems orders and new capex keep long-term growth prospects intact, say Emkay and Nuvama
SJS Enterprises stock rose 4% in Thursday's trade. Analysts believe SJS is set to benefit from premiumization in PVs, 2Ws and appliances with an addressable market set to double to ₹11,900 cr by FY28E
The Supreme Court's order to the government to reconsider the adjusted gross revenue demands is limited only to Vodafone Idea's additional dues
BHEL has rallied 10% in the last four trading sessions. Analysts at ICICI Securities believe that the company needs to ramp up execution to charter robust growth over the medium term.
PB Fintech shares rose after the company reported a strong September quarter (Q2FY26) performance, driven by robust growth in its insurance segment.
Nuvama Institutional Equities and Motilal Oswal Financial Services (MOFSL) have retained their Buy ratings on L&T, signaling confidence in the company's medium-term growth prospects.
Dr Reddy's Laboratories has received a Notice of Non-Compliance from Pharmaceutical Drugs Directorate, Canada, regarding its Abbreviated New Drug Submission for Semaglutide Injection.
Analysts at Nuvama noted that APL Apollo launched its new 'SG Premium' product line at around ₹49,500 per tonne to counter competition from secondary steel players.
CreditAccess Grameen share price fell up to 7 per cent today after Q2 results showed slower growth recovery. Analysts, however, remain positive on long-term AUM and profitability outlook
Till 10:38 AM; a combined 90.32 million equity shares representing 2.2 per cent of total equity of SAIL changed hands on the NSE and BSE.
While earnings came in ahead of expectations for M&M Financial Services, analysts remain watchful of persistently high credit costs and moderation in asset growth.
Sebi has released a consultation paper on overhauling the mutual fund regulations to simplify the rules and reduce costs for investors
At the current market price, the brokerage sees around 17 per cent upside for the stock and has set a price target of ₹3,435, based on a 32x FY28E P/E.
While Nuvama Institutional Equities has reiterated its 'Hold' rating on Shree Cement, Choice Institutional Equities has maintained a 'Sell' call, citing expensive valuations and limited upside